While about 30 to 40 percent of men older than 50 years harbor some fo
rm of prostate cancer, only about 20 to 25 percent of these cancers ar
e estimated to be clinically significant. With increasing use of new,
more effective means of detecting prostate cancer in asymptomatic scre
ening populations, concerns have been raised that large numbers of cli
nically insignificant cancers will be diagnosed, generating huge casts
and unnecessary treatment-related morbidity. This report reviews the
rationale for early detection and the accumulated data on the effectiv
eness of screening.